HK1137647A1 - Method for preparing a polymer conjugate - Google Patents
Method for preparing a polymer conjugateInfo
- Publication number
- HK1137647A1 HK1137647A1 HK10101325.2A HK10101325A HK1137647A1 HK 1137647 A1 HK1137647 A1 HK 1137647A1 HK 10101325 A HK10101325 A HK 10101325A HK 1137647 A1 HK1137647 A1 HK 1137647A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- polymer conjugate
- conjugate
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33344—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing carbamate group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polymerisation Methods In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86199506P | 2006-11-30 | 2006-11-30 | |
US316307P | 2007-11-14 | 2007-11-14 | |
PCT/US2007/024620 WO2008066902A2 (en) | 2006-11-30 | 2007-11-30 | Method for preparing a polymer conjugate |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1137647A1 true HK1137647A1 (en) | 2010-08-06 |
Family
ID=39345546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10101325.2A HK1137647A1 (en) | 2006-11-30 | 2010-02-05 | Method for preparing a polymer conjugate |
Country Status (10)
Country | Link |
---|---|
US (3) | US8354549B2 (zh) |
EP (1) | EP2104515B1 (zh) |
JP (1) | JP5277417B2 (zh) |
KR (1) | KR101441709B1 (zh) |
CN (1) | CN101583380B (zh) |
AU (1) | AU2007325631B9 (zh) |
CA (1) | CA2669541C (zh) |
HK (1) | HK1137647A1 (zh) |
MX (1) | MX2009005780A (zh) |
WO (1) | WO2008066902A2 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100330143A1 (en) * | 2003-12-04 | 2010-12-30 | University Of Utah Research Foundation | Modified macromolecules and methods of making and using thereof |
CA2653541C (en) | 2005-06-06 | 2014-12-23 | The University Of British Columbia | Polymer-based serum albumin substitute |
WO2008066902A2 (en) * | 2006-11-30 | 2008-06-05 | Nektar Therapeutics Al, Corporation | Method for preparing a polymer conjugate |
WO2009045539A2 (en) | 2007-10-05 | 2009-04-09 | Nektar Therapeutics Al, Corporation | Oligomer-corticosteroid conjugates |
JP2010013411A (ja) * | 2008-07-05 | 2010-01-21 | Hiroshi Maeda | 抗炎症剤 |
JP5588983B2 (ja) | 2008-08-11 | 2014-09-10 | ウェルズ ファーゴ バンク ナショナル アソシエイション | マルチアームポリマーアルカノエートコンジュゲート |
US8722732B2 (en) | 2009-09-29 | 2014-05-13 | Nektar Therapeutics | Oligomer-calcimimetic conjugates and related compounds |
US9059749B2 (en) * | 2009-10-02 | 2015-06-16 | Sharp Kabushiki Kaisha | Antenna port mode and transmission mode transitions |
EP2542613A4 (en) * | 2010-03-01 | 2013-12-11 | Univ British Columbia | DERIVATED HYPER BRANCHED POLYGLYCEROLS |
US8816099B2 (en) * | 2010-03-31 | 2014-08-26 | Nof Corporation | Polyfunctional polyoxyalkylene compound, and producing method and intermediate thereof |
US10894087B2 (en) | 2010-12-22 | 2021-01-19 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
US20130331443A1 (en) | 2010-12-22 | 2013-12-12 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
WO2012088433A1 (en) * | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Deuterated and/or fluorinated taxane derivatives |
US9199954B2 (en) | 2010-12-22 | 2015-12-01 | Nektar Therapeutics | Non-ring hydroxy substituted taxanes and methods for synthesizing the same |
WO2013047372A1 (ja) * | 2011-09-26 | 2013-04-04 | 株式会社糖鎖工学研究所 | Ncl法に適した、ポリペプチド断片の効率的な製造方法 |
CN104208715B (zh) * | 2013-05-31 | 2016-12-28 | 天津键凯科技有限公司 | 具有提高的药物生物活性的低分子量聚乙二醇药物结合物 |
CN106554330B (zh) * | 2015-09-26 | 2019-07-05 | 南京友怡医药科技有限公司 | 水溶性多西他赛抗癌药物化合物及其制备方法和应用 |
AU2018255458B2 (en) * | 2017-04-21 | 2020-06-25 | Brightgene Bio-Medical Technology Co., Ltd. | Multi-arm targeted anti-cancer conjugate |
CN111346234B (zh) * | 2020-03-23 | 2023-03-31 | 沈阳药科大学 | 去铁胺-八臂星型聚乙二醇结合物及其应用 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219564A (en) * | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
US5372807A (en) * | 1990-05-14 | 1994-12-13 | University Of Medicine And Dentistry Of New Jersey | Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use |
US5216115A (en) * | 1990-06-12 | 1993-06-01 | Rutgers, The State University Of New Jersey | Polyarylate containing derivatives of the natural amino acid L-tyrosine |
WO1992000748A1 (en) | 1990-07-06 | 1992-01-23 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
US5252714A (en) * | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
AU4406793A (en) * | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5840900A (en) | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5605976A (en) * | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
TW438775B (en) * | 1995-04-07 | 2001-06-07 | Pharmacia & Upjohn Co Llc | Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11) and related compounds |
US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
SG50747A1 (en) | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
WO1997033552A1 (en) | 1996-03-12 | 1997-09-18 | Pg-Txl Company, L.P. | Water soluble paclitaxel prodrugs |
US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
US6111107A (en) * | 1997-11-20 | 2000-08-29 | Enzon, Inc. | High yield method for stereoselective acylation of tertiary alcohols |
US6624142B2 (en) | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
AU2903899A (en) * | 1998-03-12 | 1999-09-27 | Shearwater Polymers Inc. | Poly(ethylene glycol) derivatives with proximal reactive groups |
US6153655A (en) * | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
JP2002542304A (ja) | 1999-04-28 | 2002-12-10 | ベクトレイムド インコーポレイテッド | 酵素的に活性化された重合薬物接合体 |
WO2000066125A1 (en) * | 1999-04-29 | 2000-11-09 | Aventis Pharma S.A. | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
WO2001005873A1 (en) * | 1999-07-14 | 2001-01-25 | Alza Corporation | Neutral lipopolymer and liposomal compositions containing same |
ATE317868T1 (de) * | 1999-12-22 | 2006-03-15 | Nektar Therapeutics Al Corp | Sterisch gehinderte derivate von wasserlöslichen polymeren |
US6602498B2 (en) * | 2000-02-22 | 2003-08-05 | Shearwater Corporation | N-maleimidyl polymer derivatives |
AU2001257577A1 (en) * | 2000-02-28 | 2001-09-03 | Shearwater Corporation | Water-soluble polymer conjugates of artelinic acid |
US6629995B1 (en) | 2000-03-31 | 2003-10-07 | Super Gen, Inc. | Camptothecin conjugates |
CN1125097C (zh) * | 2000-07-05 | 2003-10-22 | 天津大学 | 聚乙二醇支载的紫杉醇或多烯紫杉醇的前药 |
EP1301810B1 (en) | 2000-07-21 | 2008-09-10 | Services Petroliers Schlumberger | Nuclear magnetic resonance methods for extracting information about a fluid in a rock |
EP1355671A2 (en) * | 2000-11-30 | 2003-10-29 | Nektar Therapeutics Al, Corporation | Water-soluble polymer conjugates of triazine derivatives |
WO2003033525A1 (en) | 2001-10-12 | 2003-04-24 | Debio Recherche Pharmacuetique S.A. | Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament |
US20030143185A1 (en) | 2001-10-29 | 2003-07-31 | Shearwater Corporation | Polymer conjugates of protein kinase C inhibitors |
EP1453545B1 (en) | 2001-10-30 | 2007-04-18 | Nektar Therapeutics Al, Corporation | Water-soluble polymer conjugates of retinoic acid |
CN1176137C (zh) | 2002-01-15 | 2004-11-17 | 泛亚生物技术有限公司 | 多臂树杈型功能化聚乙二醇制备方法及它在药物中的应用 |
US7144978B2 (en) * | 2002-01-15 | 2006-12-05 | Pan Asia Bio Co., Ltd. | Multidrop tree branching functional polyethylene glycol, methods of preparing and using same |
AU2003234231A1 (en) | 2002-04-24 | 2003-11-10 | Rutgers | New polyarylates for drug delivery and tissue engineering |
US8591951B2 (en) * | 2002-05-15 | 2013-11-26 | Joachim B. Kohn | Tri-block copolymers for nanosphere-based drug delivery |
US6608076B1 (en) * | 2002-05-16 | 2003-08-19 | Enzon, Inc. | Camptothecin derivatives and polymeric conjugates thereof |
AU2003251405A1 (en) * | 2002-06-06 | 2003-12-22 | University Of Washington | Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
US7122189B2 (en) * | 2002-08-13 | 2006-10-17 | Enzon, Inc. | Releasable polymeric conjugates based on aliphatic biodegradable linkers |
EP1534340B1 (en) * | 2002-09-06 | 2011-11-16 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
MXPA05009137A (es) * | 2003-02-28 | 2005-10-20 | Johnson & Johnson | Composicion de liposoma para reducir la activacion del complemento inducida por liposoma. |
KR101200729B1 (ko) * | 2003-09-17 | 2012-11-13 | 넥타르 테라퓨틱스 | 다분지형 고분자 전구약물 |
EP1789097B1 (en) * | 2004-08-13 | 2014-08-13 | Rutgers, The State University | Radiopaque polymeric stents |
WO2008066902A2 (en) | 2006-11-30 | 2008-06-05 | Nektar Therapeutics Al, Corporation | Method for preparing a polymer conjugate |
-
2007
- 2007-11-30 WO PCT/US2007/024620 patent/WO2008066902A2/en active Application Filing
- 2007-11-30 CA CA2669541A patent/CA2669541C/en active Active
- 2007-11-30 CN CN2007800442170A patent/CN101583380B/zh not_active Expired - Fee Related
- 2007-11-30 JP JP2009539338A patent/JP5277417B2/ja not_active Expired - Fee Related
- 2007-11-30 MX MX2009005780A patent/MX2009005780A/es active IP Right Grant
- 2007-11-30 KR KR1020097010926A patent/KR101441709B1/ko active IP Right Grant
- 2007-11-30 US US12/515,736 patent/US8354549B2/en active Active
- 2007-11-30 EP EP07862369.1A patent/EP2104515B1/en active Active
- 2007-11-30 AU AU2007325631A patent/AU2007325631B9/en not_active Ceased
-
2010
- 2010-02-05 HK HK10101325.2A patent/HK1137647A1/xx not_active IP Right Cessation
-
2012
- 2012-11-19 US US13/680,764 patent/US8541608B2/en active Active
-
2013
- 2013-09-09 US US14/021,399 patent/US8937180B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2007325631B2 (en) | 2013-08-22 |
WO2008066902A2 (en) | 2008-06-05 |
US8937180B2 (en) | 2015-01-20 |
US8541608B2 (en) | 2013-09-24 |
US8354549B2 (en) | 2013-01-15 |
JP2010511744A (ja) | 2010-04-15 |
KR101441709B1 (ko) | 2014-09-18 |
EP2104515A2 (en) | 2009-09-30 |
US20100010194A1 (en) | 2010-01-14 |
US20130079533A1 (en) | 2013-03-28 |
CA2669541C (en) | 2014-11-18 |
CA2669541A1 (en) | 2008-06-05 |
WO2008066902A3 (en) | 2009-07-16 |
JP5277417B2 (ja) | 2013-08-28 |
CN101583380B (zh) | 2013-07-10 |
KR20090085080A (ko) | 2009-08-06 |
CN101583380A (zh) | 2009-11-18 |
AU2007325631B9 (en) | 2014-01-30 |
EP2104515B1 (en) | 2018-11-14 |
US20140005419A1 (en) | 2014-01-02 |
AU2007325631A1 (en) | 2008-06-05 |
MX2009005780A (es) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1137647A1 (en) | Method for preparing a polymer conjugate | |
GB0625995D0 (en) | Method for preparing a composition | |
EP2121811A4 (en) | PROCESS FOR PREPARING A DISPERSION | |
MX289002B (es) | Metodo para la fabricacion de polimeros. | |
EP1848679A4 (en) | PROCESS FOR THE PREPARATION OF TRIMETHYLOLPROPANE | |
ZA200903270B (en) | Process for preparing a catalyst | |
EP2060590A4 (en) | PROCESS FOR PRODUCING BRANCHED VINYL POLYMER WITH FUNCTIONAL GROUP | |
HRP20150775T1 (en) | Method for preparing hypoallergens | |
PL1988995T3 (pl) | Sposób wytwarzania katalizatora włóknistego | |
HK1111160A1 (en) | Process for preparing | |
ZA201004237B (en) | A method for metallizing a polymer | |
GB2456999B (en) | Method for preparing 2-deoxy-L-ribose | |
HK1119692A1 (zh) | 製備四甲基乙交酯的方法 | |
GB0724491D0 (en) | A method | |
PL2117856T3 (pl) | Sposób klimatyzowania pojazdu | |
GB0717877D0 (en) | Improved method for making tinted polymers | |
EP2202248A4 (en) | PROCESS FOR PREPARING HYPER BRANCHED POLYMER | |
EP2324923A4 (en) | Method for preparing a catalyst | |
EP2380896A4 (en) | PROCESS FOR PREPARING AN OLIGONUCLEOTIDE | |
IL195262A0 (en) | Process for preparing hydroxylpatite | |
GB0620898D0 (en) | A process | |
GB2444473B (en) | A process for preparing mussels | |
IL193248A0 (en) | A method for producing o-methyl-n-nitroisourea | |
GB2443411B (en) | Process for producing a monomer | |
IL192607A0 (en) | Methods for preparing activated polymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20221127 |